Stockreport

$55.7 Billion Biopharmaceutical Fermentation Systems Market Opportunities and Strategies to 2033: Development of New Bioreactors to Enhance Single-Use Upstream Operations, New Technology D...

Danaher Corporation  (DHR) 
Last danaher corporation earnings: 1/30 06:00 am Check Earnings Report
US:NYSE Investor Relations: investors.danaher.com
PDF annual growth rate (CAGR) of 9.5% from 2023 to 2033, reaching $55.7 billion in 2033. (Source: ResearchAndMarkets.com report) The main drivers of growth in the biopharm [Read more]